2m 2m 2m 2m 2m 2m 2m
PHATHOM PHARMA (PHAT)
NASDAQ
$10.94+$0.25 (+2.29%)
Price as of Jun 23, 2026 4:28 PM EDT- $852.6MMarket Cap
- 12.88%1-Year Change
- BiotechnologyIndustry
PHATHOM PHARMA (PHAT)
$10.94+$0.25 (+2.29%)
PHAT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.69 | ||
Change | -$0.19 (-1.75%) | ||
Open | $10.86 | ||
High | $11.07 | ||
Low | $10.69 | ||
Previous Close | $10.88 | ||
Volume | 670,907 | ||
30-Day Average Volume | 1,093,412 | ||
1-Week Change | -0.19% | ||
1-Month Change | -5.65% | ||
1-Year Change | 12.88% | ||
3-Year Change | -17.77% | ||
5-Year Change | -68.57% | ||
Fundamentals | |||
Shares Outstanding | 79.8M | ||
Total Assets | $305.1M | ||
Market Cap | $852.6M | ||
Enterprise Value | $835.4M | ||
Period: QTR TTM FY | |||
Revenue | $58.3M | ||
Net Income | -$30.4M | ||
Free Cash Flow | -$15.7M | ||
EBIT | -$23.9M | ||
EBITDA | -$23.8M | ||
Net Working Capital | $151.5M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -35 | ||
Enterprise Value/Revenue | 14 | ||
P/B | -3 | ||
P/E | -29 | ||
PEG | 1 | ||
Price/Free Cash Flow | -54 | ||
Price/Operating Cash Flow | -54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue